IART Investors Have Opportunity to Join Integra LifeSciences Holdings Corporation Fraud Investigation with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or “the Company”) (NASDAQ: IART) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Integra reported its financial results for Q1 2025 on May 5, 2025. The Company reported a significantly larger loss per share than in the same period of the previous year. The Company also issued full-year earnings guidance as well as its outlook for Q2 revenues that are short of consensus estimates. The Company blamed its financial results in part on inventory issues and slower customer ordering patterns. Based on this news, shares of Integra fell by more than 21.1% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [e-mail].

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.